Is premature adrenarche a risk factor for atherogenesis?

Pediatrics International

Volumn 47, Issue 1, 2005, Pages 20-25

  Güven, Ayla ^a,b   Cinaz, Peyami ^a   Bideci, Aysun ^a  

^a GAZI UNIVERSITY   (Turkey)

^b ONDOKUZ MAYIS UNIVERSITY   (Turkey)

Author keywords

Atherogenic index; Insulin like growth factor binding protein 1; Low density lipoprotein cholesterol high density lipoprotein cholesterol; Premature adrenarche; Total cholesterol high density lipoprotein cholesterol

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PRASTERONE SULFATE; SOMATOMEDIN BINDING PROTEIN 1; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADRENARCHE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BODY MASS; BODY WEIGHT; BONE AGE; CARDIOVASCULAR RISK; CHILD; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HORMONE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; LIPID BLOOD LEVEL; MEAN ARTERIAL PRESSURE; PRECOCIOUS PUBERTY; PREMATURE ADRENARCHE; PRIORITY JOURNAL; RISK FACTOR; SYSTOLIC BLOOD PRESSURE;

ADRENAL GLANDS; ARTERIOSCLEROSIS; BODY SIZE; CASE-CONTROL STUDIES; CHILD; FEMALE; HUMANS; LIPIDS; PUBERTY, PRECOCIOUS; RISK FACTORS;

EID: 14644401730     PISSN: 13288067     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1442-200x.2004.02006.x     Document Type: Article

References (29)

1. Saenger P, DiMartino-Nardi J. Premature adrenarche. J. Endocrinol. Invest. 2001; 24: 724-33.
2. Ibanez L, Potau N, Zampolli M, Rigue S, Saenger P, Carrascosa A. Hyperinsulinemia and decreased insulin-like growth factor binding protein-1 are common features in prepubertal and postpubertal girls with a history of premature pubarche. J. Clin. Endocrinol. Metab. 1997; 82: 2283-8.
3. Gibson JM, Westwood M, Young RJ, White A. Reduced insulin-like growth factor binding protein-1 (IGFBP-1) levels correlate with increased cardiovascular risk in non-insulin dependent diabetes mellitus (NIDDM). J. Clin. Endocrinol. Metab. 1996; 81: 860-3.
4. Heald AH, Siddals KW, William F et al. Low circulating levels of insulin-like growth factor binding protein-1 (IGFBP-1) are closely associated with presence of macrovascular disease and hypertension in type 2 diabetes. Diabetes 2002; 51: 2629-36.
5. Ibanez L, Potau N, Chacon P, Pascual C, Carrascosa A. Hyperinsulinemia, dyslipaemia and cardiovascular risk in girls with a history of premature pubarche. Diabetologia 1998; 41: 1057-63.
6. Orchard TJ, Becker DJ, Bates M, Kuller LH, Drash AL. Plasma insulin and lipoprotein concentrations: an atherogenic association. Am. J. Epidemiol. 1983; 118: 326-37.
7. Zavoroni I, Bonora E, Pagliara M et al. Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. N. Engl. J. Med. 1989; 320: 702-6.
8. New MI, Ghizzoni L. Congenital adrenal hyperplasia. In: Liftshitz F (ed). Pediatric Endocrinology, 4th edn. Marcel Dekker, New York, 2003; 175-92.
9. Lubchenco LO, Hansman C, Boyd E. Intrauterine growth in length and head circumference as estimated from live births at gestational ages from 26 to 42 weeks. Pediatrics 1996; 37: 403-8.
10. Tanner JM, Whitehouse RH. Clinical longitutunal standards for height, weight, height velocity, weight velocity and stages of puberty. Arch. Dis. Child. 1976; 51: 170-9.
11. Greulich WW, Pyle SI. Radiographic Atlas of Skeletal Development of the Hand and Wrist. Stanford Universty Press, CA, 1959.
12. Neyzi O. Büyüme ve gelisme bozukluklari. In: Neyzi O, Ertugrul T (eds). Pediatric. Nobel Tip Kitabevi, Istanbul, 1993; 69-114.
13. Meaney E, Alva F, Moguel A, Meaney A, Alva J, Webel R. Formula and normogram for the sphygmomanometric calculation of the mean arterial pressure. Heart 2000; 84: 64.
14. Alberada M, Rodriguez-Espinosa J, Murugo M, de Leiva A, Corcoy R. Assesment of insulin sensitivity and beta-cell function from measurements in the fasting state and during an oral glucose tolerance test. Diabetologia 2000; 43: 1507-11.
15. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin. Chem. 1972; 18: 499-502.
16. Christensen B, Glueck C, Kwiterovich P et al. Plasma cholesterol and triglyceride distributions in 13665 children and adolescent: the prevalence study of the Lipid Research Clinics Program. Pediatr. Res. 1980; 14: 194-202.
17. Tan F, Okamoto M, Suyama A, Miyamoto T. Tracking of cardiovascular risk factors and a cohort study on hyperlipidemia in rural school children in Japan. J. Epidemiol. 2000; 10: 255-61.
18. Gilbert-Barness E, Barness LA. Clinical Use of Pediatric Diagnostic Tests. Lippincott Williams & Wilkins, Philadelphia, 2003.
19. Kwiterovich PO Jr. Dyslipoproteinemia and other risk factors for atherosclerosis in children and adolescents. Atherosclerosis 1994; 108 (Suppl.): S55-71.
20. Newman PW, Freedman DS, Voors AW et al. Relation of serum lipoprotein levels and systolic blood pressure to early atherosclerosis. The Bogalusa Heart Study. N. Engl. J. Med. 1986; 314: 138-44.
21. Vuguin P, Linder B, Rosenfeld R, Saenger P, DiMartino-Nardi J. The roles of insulin sensitivity, insulin-like growth factor-1 and insulin-like growth factor binding proteins 1 and 3 in the hyperandrogenism of African-American and Caribbean-Hispanic girls with premature adrenarche. J. Clin. Endocrinol. Metab. 1999; 84: 2037-42.
22. Ibanez L, Potau N, Zampolli M, Rigue S, Saenger P, Carrascosa A. Hyperinsulinemia and decreased insulin-like growth factor-binding protein-1 are common features in prepubertal and post pubertal girls with a history of premature pubarche. J. Clin. Endocrinol. Metab. 1997; 82: 2283-8.
23. Nestler JE, Clore JN, Blackard WG. Dehydroepiandrosterone: the 'missing link' between hyperinsulinemia and atherosclerosis? FASEB J. 1992; 6: 3073-5.
24. Okamoto K. Distribution of dehydroepiandrosterone sulfate and relationship between its level and serum lipid levels in a rural Japanese population. J. Epidemiol. 1998; 8: 285-91.
25. Kiechl S, Willert J, Bonora E, Schwarz P, Xu Q. No association between dehydroepiandrosterone sulfate and development atherosclerosis in a prospective population study (Bruneck Study). Atheroscler. Thromb. Vasc. Biol. 2000; 20: 1094-100.
26. Sulcova J, Hill M, Hampl R et al. Effects of trandermal application of DHEA on the levels of steroids, gonadotropins and lipids in men. Physiol. Res. 2000; 49: 685-93.
27. Ibanez L, Potau N, Virdis R et al. Pospubertal outcome in girls diagnosed of premature pubarche during childhood: increased frequency of functional ovarian hyperandrogenism. J. Clin. Endocrinol. Metab. 1993; 76: 1599-603.
28. Ibanez L, Potau N, deZegher F. Precocious pubarche, dyslipidemia, and low IGF binding protein-1 in girls: relation to reduced prenatal growth. Pediatr. Res. 1999; 46: 320-2.
29. Hoffman PL, Cutfield WS, Robinson EM et al. Insulin resistance in short children with intrauterine growth retaration. J. Clin. Endocrinol. Metab. 1997; 82: 402-6.